160 likes | 247 Vues
This presentation delves into the economic impact of diabetes in Canada, discussing the current costs, prevalence, and future projections. The report explores interventions and strategies to reduce the burden of diabetes and presents the Canadian Diabetes Cost Model, a unique tool for projecting costs and benefits of preventative initiatives.
E N D
An Economic Tsunami – The cost of diabetes in Canada Presentation to the First Canadian Summit on Metabolic Surgery for Type 2 DiabetesThursday, May 6th, 2010Margaret Beatty, RN, MHSc, CHE Vice-President, Research, Professional Education & Government AffairsRobin SomervilleDirector, The Centre for Spatial Economics
•A member-driven charitable association•A presence across Canada• Supported by a volunteer network Who we are 1
What we do • Programs and services • Research • Education and information • Advocacy
Objectives of the Report • Define the cost/burden of diabetes • Create a forecasting model • Efficacy of interventions
Expert Advisory Committee • Dr. Jeff Johnson, University of Alberta • Dr. Paula Stewart, Public Health Agency of Canada • Glenn Robbins, Public Health Agency of Canada • Chris Cameron, Canadian Agency for Drugs and Technologies in Health • Denis Bélanger, Canadian Agency for Drugs and Technologies in Health • David Whiting, International Diabetes Federation • Ole Henrikson, Novo Nordisk • Nik Nikolav, Novo Nordisk • Tanya Wymer, Novo Nordisk • Robyn Tamblyn, McGill University • Michael Wolfson, Statistics Canada • Mike McCracken, Informetrica • Paul Jacobson, Informetrica • Robin Somerville, Centre for Spatial Economics
Key Findings Cost of Diabetes in Canada: • $12.2 billion today • $16.9 billion by 2020
Key Findings Prevalence of Diabetes in Canada: • 2.5 million have been diagnosed with diabetes (3 million have diabetes) • 1.2 million more will be diagnosed over next decade • Population with diabetes is 7.3% increasing to 9.9% by 2020 • 1 in 4 in four Canadians either has diabetes or prediabetes
An Ounce of Prevention • Interventions = reduce costs • 2% reduction = 9% (direct) & 7% (indirect) cost savings
Need for Action Key areas should include: • Canadian Diabetes Strategy/Aboriginal Diabetes Initiative • Tax strategies • Research
The Canadian Diabetes Cost Model The Model Can: • Project the costs, incidence and prevalence of diabetes • Determine the cost benefit of initiatives designed to delay or prevent the onset of type 2 diabetes • Be developed further to provide province-specific data
The Canadian Diabetes Cost Model Why it is unique? • It is independent • It uses Canadian data • It includes indirect costs
The Canadian Diabetes Cost Model Key Assumptions: • Population growth • Incidence rates • Mortality rates • Occurrence rates (hospitalization, doctor visits, medication, etc.) • Per unit costs (2005 dollars)
Key Drivers: Prevalence Main drivers: • Population increases • Aging population • Rising incidence rates • Demographics (changes in ethnic mix), obesity rates & sedentary lifestyles
Key Drivers: Costs Indirect: • Mortality costs • Long-term disability costs Direct: • Direct hospitalization • CVD-related costs • General practitioner visit costs • Specialist visit costs • Diabetes medication costs
Next Steps • Update the Model (April – October 2010) • Provincial Models (NB in May 2010, ON in June 2010) • Regional & Community Models (November 2010) • Impact Studies (2011) • Detailed Treatment of Co-morbidities (2011-2012)
Thank you Thank you for helping us lead the fight against diabetes by helping people with diabetes live healthy lives while we work to find a cure. Our report, An Economic Tsunami: the cost of diabetes in Canada, is available in English and French at diabetes.ca/economicreport